Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancer

This study aims to discover novel immune biomarkers specific to EOCRC that may permit the development of a non-invasive, peripheral blood-based “liquid Immunoscore” that may integrate specific quantitative measurements. By contrasting the immune landscapes of EOCRC and LOCRC based on key immune cell...

Descripción completa

Detalles Bibliográficos
Autores: Sánchez-Menéndez, Clara, Rodríguez-Pérez, Jaime, Fuertes, Daniel, Leguizamon, Valentina, González-Sanmartin, María, Mateos, Elena, Cervero, Miguel, San José Martínez, Esther, Sanz, Gonzalo, Álvaro, Edurne, Et. al.
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universidad Europea (UEM)
Repositorio:ABACUS. Repositorio de Producción Científica
Idioma:inglés
OAI Identifier:oai:abacus.universidadeuropea.com:11268/16617
Acceso en línea:https://hdl.handle.net/11268/16617
Access Level:acceso abierto
Palabra clave:Neoplasias colorrectales
Diagnóstico precoz
Inmunidad
Cáncer
Medicina preventiva
Investigación médica
Goal 3: Ensure healthy lives and promote well-being for all at all ages
Descripción
Sumario:This study aims to discover novel immune biomarkers specific to EOCRC that may permit the development of a non-invasive, peripheral blood-based “liquid Immunoscore” that may integrate specific quantitative measurements. By contrasting the immune landscapes of EOCRC and LOCRC based on key immune cell subsets, exhaustion markers, soluble cytokines, and metabolic capacity, we seek to improve early detection, enable more timely and personalized treatment, and ultimately identify individuals under 50 at high risk for EOCRC before tumors become clinically detectable.